<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:news="http://www.google.com/schemas/sitemap-news/0.9">
  <url><loc>https://oncdata.com/psilocybin-assisted-therapy-for-depression-in-advanced-lung-cancer</loc><news:news><news:publication><news:name>Oncology Data Advisor</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-19T14:55:22.298Z</news:publication_date><news:title>Can Psilocybin-Assisted Therapy Reduce Depression in Advanced Lung Cancer? </news:title></news:news></url>
  <url><loc>https://oncdata.com/article/4204770e-9c26-487d-897f-9a870cac509f</loc><news:news><news:publication><news:name>Oncology Data Advisor</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-19T12:50:02.186Z</news:publication_date><news:title>Optimal Surgical Margin in Hepatocellular Carcinoma After HAIC Conversion Therapy</news:title></news:news></url>
  <url><loc>https://oncdata.com/article/896d80c6-f9e0-4acd-ae9d-71300379074c</loc><news:news><news:publication><news:name>Oncology Data Advisor</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-19T12:50:02.003Z</news:publication_date><news:title>Ribociclib With Endocrine Therapy Delays QOL Deterioration in HR+/HER2- Breast Cancer</news:title></news:news></url>
  <url><loc>https://oncdata.com/article/cdf6f9ec-5756-430d-b74e-c191b443dc1b</loc><news:news><news:publication><news:name>Oncology Data Advisor</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-19T02:49:43.191Z</news:publication_date><news:title>SBRT vs Sublobar Resection for Stage IA NSCLC: Causal Inference Analysis in SEER-Medicare</news:title></news:news></url>
  <url><loc>https://oncdata.com/article/02ae26cb-abc3-42dc-a846-ca4a2a801f72</loc><news:news><news:publication><news:name>Oncology Data Advisor</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-19T02:49:42.996Z</news:publication_date><news:title>EHA Guidelines and COSMIN Systematic Review on Patient-Reported Outcomes in Ph-Negative MPN Trials</news:title></news:news></url>
  <url><loc>https://oncdata.com/article/c304f690-8167-4367-90ac-46565e9dea26</loc><news:news><news:publication><news:name>Oncology Data Advisor</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-18T22:49:47.463Z</news:publication_date><news:title>Tandem ASCT Improves Event-Free Survival in High-Risk Neuroblastoma</news:title></news:news></url>
  <url><loc>https://oncdata.com/article/0a289da0-b2b2-4dd1-b20b-a56426e409d4</loc><news:news><news:publication><news:name>Oncology Data Advisor</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-18T22:49:47.328Z</news:publication_date><news:title>Cutaneous irAEs Linked to Multiorgan Toxicities With Checkpoint Inhibitors</news:title></news:news></url>
  <url><loc>https://oncdata.com/article/d72b6589-85b0-46f3-8cb8-beb305ac0ddf</loc><news:news><news:publication><news:name>Oncology Data Advisor</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-18T12:49:38.857Z</news:publication_date><news:title>Aromatase Inhibitors vs Tamoxifen and Incident Intracranial Meningioma Risk in Breast Cancer</news:title></news:news></url>
  <url><loc>https://oncdata.com/article/7593c94d-e2ba-40f4-93b6-7581dbf7f94d</loc><news:news><news:publication><news:name>Oncology Data Advisor</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-18T12:49:38.636Z</news:publication_date><news:title>Accelerated Partial-Breast Versus Whole-Breast Irradiation in Low-Risk Invasive Breast Cancer</news:title></news:news></url>
  <url><loc>https://oncdata.com/article/d9633f8a-ace9-4e1c-931c-4b3bbcb09396</loc><news:news><news:publication><news:name>Oncology Data Advisor</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-18T02:49:34.851Z</news:publication_date><news:title>Adjuvant ICI and Chemotherapy Linked to Longer DFS in High-Risk UTUC</news:title></news:news></url>
  <url><loc>https://oncdata.com/article/b9d807cf-68bf-4c65-8967-7727387f93e1</loc><news:news><news:publication><news:name>Oncology Data Advisor</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-18T02:49:34.693Z</news:publication_date><news:title>Preoperative Staging Completion Rates in Medicare Rectal Cancer Proctectomy</news:title></news:news></url>
  <url><loc>https://oncdata.com/article/87b116d5-c0c0-4cd5-bb1c-063c47729370</loc><news:news><news:publication><news:name>Oncology Data Advisor</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-17T22:49:40.314Z</news:publication_date><news:title>Complex Karyotype and Non-BTK Mutations Linked to BTK Inhibitor Resistance in CLL</news:title></news:news></url>
  <url><loc>https://oncdata.com/article/0ad02815-bbac-4add-b7d1-b6ab8949a8c3</loc><news:news><news:publication><news:name>Oncology Data Advisor</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-17T22:49:40.214Z</news:publication_date><news:title>Updated CAP-ASCP Guideline on HER2 Testing in Advanced Gastroesophageal Adenocarcinoma</news:title></news:news></url>
</urlset>